Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study

Detalles Bibliográficos
Autores principales: Mago, Rajnish, Forero, Giovanna, Greenberg, William M., Gommoll, Carl, Chen, Changzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079528/
http://dx.doi.org/10.1007/s40261-013-0133-6
_version_ 1782323861608464384
author Mago, Rajnish
Forero, Giovanna
Greenberg, William M.
Gommoll, Carl
Chen, Changzheng
author_facet Mago, Rajnish
Forero, Giovanna
Greenberg, William M.
Gommoll, Carl
Chen, Changzheng
author_sort Mago, Rajnish
collection PubMed
description
format Online
Article
Text
id pubmed-4079528
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-40795282014-07-25 Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study Mago, Rajnish Forero, Giovanna Greenberg, William M. Gommoll, Carl Chen, Changzheng Clin Drug Investig Erratum Springer International Publishing 2013-10-12 2013 /pmc/articles/PMC4079528/ http://dx.doi.org/10.1007/s40261-013-0133-6 Text en © Springer International Publishing Switzerland 2013
spellingShingle Erratum
Mago, Rajnish
Forero, Giovanna
Greenberg, William M.
Gommoll, Carl
Chen, Changzheng
Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
title Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
title_full Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
title_fullStr Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
title_full_unstemmed Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
title_short Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
title_sort erratum to: safety and tolerability of levomilnacipran er in major depressive disorder: results from an open-label, 48-week extension study
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079528/
http://dx.doi.org/10.1007/s40261-013-0133-6
work_keys_str_mv AT magorajnish erratumtosafetyandtolerabilityoflevomilnacipranerinmajordepressivedisorderresultsfromanopenlabel48weekextensionstudy
AT forerogiovanna erratumtosafetyandtolerabilityoflevomilnacipranerinmajordepressivedisorderresultsfromanopenlabel48weekextensionstudy
AT greenbergwilliamm erratumtosafetyandtolerabilityoflevomilnacipranerinmajordepressivedisorderresultsfromanopenlabel48weekextensionstudy
AT gommollcarl erratumtosafetyandtolerabilityoflevomilnacipranerinmajordepressivedisorderresultsfromanopenlabel48weekextensionstudy
AT chenchangzheng erratumtosafetyandtolerabilityoflevomilnacipranerinmajordepressivedisorderresultsfromanopenlabel48weekextensionstudy

Ejemplares similares